-
-
-
-
-
-
-
Hims & Hers Health Inc. set to report Q4 earnings with guidance cut fears mounting after compounded semaglutide fallout
-
-
-
-
-
-
-
Morgan Stanley Reiterates Equalweight Rating on Hims and Hers (HIMS)
-
-
-
-
-
-
-
Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025
-
-
-
-
-
-
-
Hims & Hers to Announce Second Quarter 2025 Financial Results on August 4, 2025
-
-
-
-
-
-
-
Hims and Hers (HIMS) PT Raised to $42 at Leerink Partners
-
-
-
-
-
-
-
Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025
-
-
-
-
-
-
-
Hims & Hers Health, Inc. (HIMS) Misses Q4 EPS by 6c, Revenue Beats, Offers Guidance
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

